Breast and ovarian cancers are often linked to a genetic predisposition, most commonly through mutations in the breast cancer susceptibility genes BRCA1 and BRCA2, but also other genes, such as FANCJ/BRIP1, are associated with an increased disease risk. This evidence concerns the gene BRIP1 and breast carcinoma.